Central Venous Catheter-related Infection
📧 Sign up to get email alerts when something new happens for Central Venous Catheter-related Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-11-15FDA Approved: DEFENCATH — Original Application (CorMedix Inc.)
Defencath is a taurolidine and heparin catheter-lock solution that received FDA approval via CorMedix's original NDA.